Mark Schneyer
Vermogen: 2 M $ op 31-07-2026
Vermogen: 2 M $ op 31-07-2026
Mark C.
Schneyer is Chief Financial Officer & Executive Vice President at ACADIA Pharmaceuticals, Inc. since 2021.
Previously, Mr. Schneyer was Vice President-Business Development at Pfizer Inc. from 2019 to 2020.
Mr. Schneyer completed undergraduate studies at The Wharton School of the University of Pennsylvania in 1996.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-08-2026 | 67.828 ( 0,04% ) | 2 M $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Financieel Directeur/CFO | 10-09-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01-05-2020 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
ACADIA Pharmaceuticals, Inc.
ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau